Country sites EN Home About Products Investors Sustainability Newsroom Careers Contact Hikma Awards and achievements "The only limits are limits we place on ourselves. You can accomplish just about anything with wisdom and reason, but only if you remain optimistic." Samih Darwazah, Hikma Founder Company of the Year Global Generics and Biosimilars Awards October 2017 Leader of the Year Global Generics and Biosimilars Awards October 2016 Best Company in an Emerging Market Award 11th annual SCRIP Awards December 2015 Acquisition of the Year Award Global Generics and Biosimilars Awards October 2015 Company of the Year, EMEA Award Global Generics and Biosimilars Awards October 2014 Founder and Chairman Mr Samih Darwazah selected as the first Emerging Markets Leader of the SCRIP 100 list SCRIP 100 List December 2013 Healthcare Company of the Year Arabian Business Achievements Awards November 2012 Client Leadership Award The International Finance Corporation October 2012 Best Audit Disclose for FTSE 250 Company ICSA/Hermes Transparency in Governance Award November 2011 Launch of the Samih Darwazah Center for Innovation Management and Entrepreneurship The American University of Beirut January 2011 Best Company in an Emerging Market Award 5th Annual SCRIP Awards November 2009 Late founder Samih Darwazah honored with prestigious recognition from HM King Abdullah II Jordan's First State Centennial Awards May 2021 Latest news Hikma and Winterlight Labs collaborate to develop biomarkers for Schizophrenia patients in MENA 23 November 2021 Hikma Ventures invests in biotechnology company BioSapien Inc., developer of a patented drug-delivery device intended to reduce the system-wide side effects of chemotherapy treatments 11 November 2021 Hikma continues strong 2021 performance and reiterates full year guidance 4 November 2021 About Awards and achievements Back to top Useful links About Products Investors News Careers Contact Worldwide Leadership Stay in touch Subscribe to our newsletter Follow us instagram Created with Sketch. © Hikma Pharmaceuticals PLC 2021 Terms of use Cookie policy Disclaimer Privacy policy Community guidelines Our website uses cookies to improve your experience. Some of the cookies we use are essential for parts of our website to operate. By using our website without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.